Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 46.83%
March 31, 2026 45.99%
December 31, 2025 45.62%
September 30, 2025 45.85%
June 30, 2025 43.39%
March 31, 2025 43.35%
December 31, 2024 44.43%
September 30, 2024 42.94%
June 30, 2024 40.53%
March 31, 2024 45.27%
December 31, 2023 45.59%
September 30, 2023 42.01%
June 30, 2023 49.64%
March 31, 2023 48.88%
December 31, 2022 50.78%
September 30, 2022 50.30%
June 30, 2022 49.52%
March 31, 2022 48.75%
December 31, 2021 51.12%
September 30, 2021 48.99%
June 30, 2021 49.83%
March 31, 2021 48.80%
December 31, 2020 48.37%
Date Value
September 30, 2020 49.04%
June 30, 2020 48.90%
March 31, 2020 47.58%
December 31, 2019 48.04%
September 30, 2019 44.02%
June 30, 2019 42.08%
March 31, 2019 38.09%
December 31, 2018 38.35%
September 30, 2018 39.76%
June 30, 2018 42.46%
March 31, 2018 36.30%
December 31, 2017 31.02%
September 30, 2017 28.32%
June 30, 2017 28.10%
March 31, 2017 29.29%
December 31, 2016 31.52%
September 30, 2016 30.79%
June 30, 2016 26.40%
March 31, 2016 25.20%
December 31, 2015 22.32%
September 30, 2015 54.29%
June 30, 2015 57.24%
March 31, 2015 73.00%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
LTC Properties, Inc. 55.12%
National Health Investors, Inc. 48.52%
Omega Healthcare Investors, Inc. 70.31%
Ventas, Inc. 17.78%
Sabra Health Care REIT, Inc. 37.17%